Cargando…

Removal of inflammatory mediators by continuous renal replacement therapy in severe sepsis

Detalles Bibliográficos
Autores principales:	Tomas, E, Lafuente, E, Vera, B, Fernandes, M, Silva, J, Santos, F, Moura, F, Santos, P, Lopes, R, Calder, P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084155/ http://dx.doi.org/10.1186/cc7433

Ejemplares similares

Evaluation of functional differences between two anticoagulation methods used in continuous renal replacement therapy in critical patients
por: Goulão, V, et al.
Publicado: (2014)

Characterization of organophosphate poisoning patients in the ICU: a 4-year review
por: Sá, A, et al.
Publicado: (2009)

Protein losses in continuous renal replacement therapies
por: Rodigues, MG, et al.
Publicado: (2005)

Prognostic value of routinely assessed serum biomarkers in septic shock
por: Lafuente, E, et al.
Publicado: (2011)

Amino acid adherence in continuous renal replacement therapies
por: Rodrigues, MG, et al.
Publicado: (2005)

Functional protein C levels in septic patients
por: Lafuente, E, et al.
Publicado: (2007)

Hybrid renal replacement techniques vs continuous haemodiafiltration in haemodynamically unstable patients
por: Marcelino, P, et al.
Publicado: (2006)

Timing of the initiation of continuous renal replacement therapy and clinical outcome in patients with severe sepsis and septic shock
por: Cho, S
Publicado: (2012)

High fluid volume removal with continuous renal replacement therapy as a therapeutic option for early posttraumatic acute respiratory distress syndrome
por: Sorrentino, L, et al.
Publicado: (2008)

Continuous renal replacement and removal of inflammatory mediators in sepsis: Still an open debate
por: Buonanno, Pasquale, et al.
Publicado: (2021)

Glutamine serum, adherence and losses in continuous renal replacement therapies in critically ill patients
por: Rodigues, MG, et al.
Publicado: (2005)

Determinants of renal recovery and mortality inpatients undergoing continuous renal replacement therapy in the ICU
por: Gleeson, PJ, et al.
Publicado: (2015)

Pharmacokinetics of meropenem during continuous renal replacement therapy in critically ill patients
por: Solé Violan, J, et al.
Publicado: (2014)

Continuous renal replacement therapy with the adsorbent membrane oXiris in septic patients: a clinical experience
por: Turani, F, et al.
Publicado: (2013)

Continuous renal replacement therapy: are we getting the dose right?
por: Martin, S, et al.
Publicado: (2010)

Tedizolid clearance by in vitro continuous renal replacement therapy model
por: Lewis, SJ, et al.
Publicado: (2015)

Protein losses and nitrogen balance during continuous renal replacement therapy
por: Hayami, H, et al.
Publicado: (2011)

Metabolic disturbances encountered during pediatric continuous renal replacement therapy
por: Soysal, D, et al.
Publicado: (2006)

Evaluation of microcirculation before and during continuous renal replacement therapy and the impact of dose prescription
por: Pipili, C, et al.
Publicado: (2012)

Pharmacokinetic/pharmacodynamic analysis of linezolid in critically ill patients with severe sepsis treated with renal replacement therapy
por: Barrasa González, H, et al.
Publicado: (2015)

Recovery of renal function after acute kidney injury requiring continuous renal replacement therapy
por: Jung, HY, et al.
Publicado: (2014)

Preliminary report of an enoxaparin dose protocol based on anti-Xa activity in continuous renal replacement therapy
por: Costa, JLF, et al.
Publicado: (2007)

Timing of continuous renal replacement therapies in acute kidney injury patients after cardiac surgery
por: Cardenas Campos, P, et al.
Publicado: (2015)

Obesity and inflammatory markers in severe sepsis
por: Simon, P, et al.
Publicado: (2013)

Novel carbon dioxide removal device driven by a renal-replacement system without hemofilter: an experimental approach and validation
por: Godet, T, et al.
Publicado: (2014)

Safety and efficacy of extracorporeal CO(2) removal combined with continuous renal replacement therapy in patients presenting both acute respiratory distress syndrome and acute kidney injury
por: Allardet-Servent, J, et al.
Publicado: (2015)

Anticoagulation during continuous renal replacement therapy with lepirudin in patients with heparin-induced thrombocytopenia
por: Schroeder, T, et al.
Publicado: (2005)

Post-mortem findings in critically ill patients treated with continuous renal replacement therapy
por: Crippa, IA, et al.
Publicado: (2015)

Protein content with parenteral nutrition in critical and hospitalized patients with continuous renal replacement therapies
por: Baez, AV, et al.
Publicado: (2015)

Preventing continuous renal replacement therapies (CRRT)-induced hypophosphatemia using a phosphate-containing CRRT solution in the setting of regional citrate anticoagulation
por: Pistolesi, V, et al.
Publicado: (2014)

Stability of citrate and calcium dosing in citrate renal replacement therapy
por: Sadaat, F, et al.
Publicado: (2015)

Utilization of slow low-efficiency dialysis may help to optimize the need for continuous renal replacement therapy in Indian ICUs
por: Majumdar, A, et al.
Publicado: (2009)

Renal replacement in critically ill patients: the age factor
por: Occhigrossi, F, et al.
Publicado: (2004)

Timing for initiation of continuous renal replacement therapy in patients with septic shock and acute kidney injury
por: Shum, HP, et al.
Publicado: (2012)

Coagulopathy of liver disease does not increase the filter life during continuous renal replacement therapy
por: Agarwal, B, et al.
Publicado: (2009)

Comparison between nafamostat mesilate and unfractionated heparin as anticoagulant during continuous renal replacement therapy
por: Makino, S, et al.
Publicado: (2015)

Georeferencing sepsis in São Paulo city
por: Silva, E, et al.
Publicado: (2011)

Weight gain a risk factor for mortality in patients with acute kidney injury requiring continuous renal replacement therapy
por: Maldonado Toral, C, et al.
Publicado: (2015)

Elimination rates of electrolytes, vitamins and trace elements during continuous renal replacement therapy with citrate CVVHD: influence of treatment dose
por: Von Freyberg, P, et al.
Publicado: (2014)

Continuous L-arginine infusion does not deteriorate the haemodynamic condition in patients with severe sepsis
por: Luiking, Y, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_8ecsgh8u8v55dt3kajuitvlr73